短期抗生素治疗:抗菌药物管理的下一个前沿
Donald Sheppard1,2,3,4
1Antimicrobial Resistance Task Force, Public Health Agency of Canada, Ottawa, ON.
概括
较短的抗生素疗程对常见感染有效,降低了风险. 尽管有证据,但长时间的抗生素持续存在,需要策略来制过度使用和打击抗菌素耐药性.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 抗生素耐药性是一个日益增长的威胁,需要明智地使用抗生素.
- 长时间的抗生素疗程经常被处方,尽管有证据支持更短的持续时间.
- 短期抗生素治疗在许多感染中提供了可比的疗效和减少不良事件.
研究的目的:
- 审查抗生素处方时间指南的演变.
- 检查支持短期抗生素治疗的证据.
- 确定采用短期治疗的障碍,并提出减少长期使用抗生素的解决方案.
主要方法:
- 关于抗生素处方实践和耐药性的文献综述.
- 临床试验数据分析短期与传统持续时间的抗生素治疗.
- 探索影响抗生素处方习惯的因素.
主要成果:
- 证据支持短期抗生素对特定感染的疗效和安全性.
- 尽管有可用的指南,但长期使用抗生素仍然很普遍.
- 短期采用障碍包括临床惯性和缺乏意识.
结论:
- 优化抗生素持续时间对于保持有效性和打击耐药性至关重要.
- 实施克服障碍的战略可以促进短期抗生素治疗的普及.
- 减少不适当的长时间使用抗生素对公共健康至关重要.
更多相关视频
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
4.7K
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
26.2K
相关概念视频
Antibiotic Selection
53.8K
Overview
53.8K
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
410
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
410
Antimicrobial Proteins
997
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
997
